The Bonnie J. Addario Lung Cancer Foundation Honors Leading Lung Cancer Researcher with the 2016 Addario Lectureship Award

Dr. Scagliotti's areas of research interest include: experimental studies on basic and clinical applied research on lung cancer, including translational research; molecular targeted therapies in lung cancer; and lung cancer chemotherapy, including investigators' initiated studies.

"We are so pleased to present the Addario Lectureship Award this year to Dr. Scagliotti for his incredible leadership, research, and long-term dedication to the treatment of lung cancer," said Bonnie J. Addario, 10-year lung cancer survivor and founder of the ALCF.

Each year the ALCF recognizes one special leader who is making great strides to eradicate lung cancer and fight for the lives affected by this disease. According to the American Cancer Society, more than 228,000 people in the United States will be diagnosed this year with lung cancer, and nearly 160,000 lung cancer patients will die. Cancer UK estimates that worldwide, nearly two million people are diagnosed with lung cancer each year.  

Dr. Scagliotti earned his medical degree and completed postgraduate training in respiratory medicine, internal medicine, and medical oncology at the University of Torino. Dr. Scagliotti is a member of several scientific societies, including the Italian Society of Respiratory Medicine, The Italian Association of Medical Oncology, the European Respiratory Society, the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer.

From 2002 to 2005 he was member of the International Affair Committee of the American Society of Clinical Oncology and from 2003-07 Executive Board member of the International Association for the Study of Lung Cancer. He is currently serving on the Publication Committee and he served in Program Committee of the American Society of Clinical Oncology in the period 2005-07.

Dr. Scagliotti is a manuscript reviewer for several scientific journals. He currently serves on the editorial boards of Critical Review in Oncology and Hematology, and Oncology News. He is Associate Editor for Journal of Thoracic Oncology and International Editor for Clinical Lung Cancer. He is the author or co-author of more than 150 publications in peer-reviewed journals.

"Dr. Scagliotti's work to bring together the international world of lung cancer research is inspiring to us all and we are so pleased to recognize and elevate his work through the Addario Lectureship Award," said Addario.  

Past Addario Lectureship Award recipients include:

• 2015 Recipient:, Fred R. Hirsch, M.D., Ph.D, CEO of the International Association for the Study of Lung Cancer (ISLAC)
• 2014 Recipient: Roy S. Herbst, M.D., Ph.D., Ensign Professor of Medicine and Chief of Medical Oncology, Yale Cancer Center
• 2013 Recipient: Tony Mok, M.D., Professor in the Department of Clinical Oncology, Chinese University of Hong Kong in Prince of Wales Hospital in Hong Kong
• 2012 Recipient: D. Ross Camidge, M.D., Ph.D., Director of the Thoracic Oncology Clinical Program and Associate Director for Clinical Research, Colorado University Cancer Center
• 2011 Recipient: William Pao , M.D., Ph.D., Associate Professor of Medicine, Ingram Associate Professor of Cancer Research, Director, Personalized Cancer Medicine, Vanderbilt Ingram Cancer Center
• 2010 Recipient: David R. Gandara , M.D., Associate Director, Clinical Research, UC Davis Cancer Center
• 2009 Recipient: Harvey Pass , M.D., B.A., Director of the Division of Thoracic Surgery and Chief of Thoracic Surgery, New York University Medical Center
• 2008 Recipient: Paul A. Bunn, Jr. M.D., Principal Investigator and Director, University of Colorado Cancer Center

"Giorgio Scagliotti is a modern day man for all seasons, a truly remarkable depth and breadth of expertise," said Dr. Gandra,  2010 award recipient.

The ALCF has supported the Lung Cancer Congress for the past nine years and serves as a co-sponsor along with the IASLC. The annual three-day event provides physicians with practical information about the clinical implications of lung cancer screening, the latest clinical data impacting the treatment of lung cancer and novel agents and strategies that are changing the future of lung cancer therapy.

About the Bonnie J. Addario Lung Cancer Foundation
The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest international philanthropies (patient-founded, patient-focused and patient-driven) devoted exclusively to eradicating lung cancer through research, early detection, education and treatment. The Foundation's goal is to work with a diverse group of physicians, organizations, industry partners, individuals, patients, survivors and their families to identify solutions and make timely and meaningful change and turn lung cancer into a chronically managed disease by 2023. The ALCF was established on March 1, 2006, as a 501c(3) non-profit organization and has raised more than $30 million for lung cancer research and related programs.

Photo - http://photos.prnewswire.com/prnh/20160801/394806
Logo - http://photos.prnewswire.com/prnh/20160225/337506LOGO

SOURCE Bonnie J. Addario Lung Cancer Foundation